![Marcin Gondek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcin Gondek
Chief Executive Officer at Synexus Clinical Research GmbH
Network origin in Marcin Gondek first degree
Entity | Entity type | Industry | |
---|---|---|---|
Synexus Clinical Research GmbH
![]() Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marcin Gondek via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Synexus Clinical Research Ltd.
![]() Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | Medical/Nursing Services | President | |
Future Meds Ltd.
![]() Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistics
International
United Kingdom | 3 |
Sectoral
Health Services | 2 |
Commercial Services | 2 |
Operational
Chief Executive Officer | 3 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Most connected contacts
Insiders | |
---|---|
Radoslaw Janiak | 3 |
Iwona Tongbhoyai | 1 |
- Stock Market
- Insiders
- Marcin Gondek
- Company connections